Very good chance they will get Vitiligo approved as another indication, valuation is ridiculously low if you start to price that in. Jefferies, out of all the analysts, did just that and came up with a PT ~$50.
All IMO DYOR
- Forums
- ASX - By Stock
- Disc Medicine - Best comparison stock to Clinuvel
Very good chance they will get Vitiligo approved as another...
-
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$15.42 |
Change
-0.240(1.53%) |
Mkt cap ! $772.1M |
Open | High | Low | Value | Volume |
$15.60 | $15.60 | $15.21 | $803.4K | 51.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 338 | $15.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.43 | 211 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 338 | 15.330 |
1 | 338 | 15.300 |
1 | 338 | 15.280 |
1 | 338 | 15.250 |
1 | 338 | 15.220 |
Price($) | Vol. | No. |
---|---|---|
15.430 | 211 | 1 |
15.500 | 214 | 2 |
15.550 | 338 | 1 |
15.580 | 338 | 1 |
15.600 | 1247 | 3 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |